JPMorgan Chase & Co’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.9M Buy
208,141
+23,019
+12% +$3.97M ﹤0.01% 1384
2025
Q1
$28.9M Buy
185,122
+107,695
+139% +$16.8M ﹤0.01% 1466
2024
Q4
$10.7M Buy
77,427
+37,593
+94% +$5.18M ﹤0.01% 2188
2024
Q3
$5.95M Sell
39,834
-25,428
-39% -$3.8M ﹤0.01% 2537
2024
Q2
$8.9M Buy
65,262
+37,256
+133% +$5.08M ﹤0.01% 2180
2024
Q1
$4.23M Sell
28,006
-33,858
-55% -$5.12M ﹤0.01% 2668
2023
Q4
$7.79M Sell
61,864
-78,512
-56% -$9.89M ﹤0.01% 2282
2023
Q3
$13.1M Buy
140,376
+3,231
+2% +$303K ﹤0.01% 1792
2023
Q2
$12.2M Buy
137,145
+61,148
+80% +$5.46M ﹤0.01% 1895
2023
Q1
$8.15M Sell
75,997
-747
-1% -$80.1K ﹤0.01% 2137
2022
Q4
$9.37M Sell
76,744
-14,375
-16% -$1.76M ﹤0.01% 1970
2022
Q3
$9.41M Sell
91,119
-33,092
-27% -$3.42M ﹤0.01% 1901
2022
Q2
$11.5M Buy
124,211
+105,402
+560% +$9.8M ﹤0.01% 1778
2022
Q1
$2.21M Buy
18,809
+1,530
+9% +$180K ﹤0.01% 3098
2021
Q4
$2.32M Buy
17,279
+10,317
+148% +$1.39M ﹤0.01% 3131
2021
Q3
$1.11M Buy
6,962
+1,173
+20% +$187K ﹤0.01% 3541
2021
Q2
$762K Sell
5,789
-38,699
-87% -$5.09M ﹤0.01% 3783
2021
Q1
$5.73M Buy
44,488
+36,016
+425% +$4.64M ﹤0.01% 2545
2020
Q4
$1.41M Sell
8,472
-48,411
-85% -$8.07M ﹤0.01% 3180
2020
Q3
$8.66M Buy
56,883
+17,611
+45% +$2.68M ﹤0.01% 1875
2020
Q2
$5.81M Buy
39,272
+3,402
+9% +$503K ﹤0.01% 2063
2020
Q1
$4.04M Buy
35,870
+17,705
+97% +$1.99M ﹤0.01% 2153
2019
Q4
$2.53M Buy
18,165
+10,940
+151% +$1.52M ﹤0.01% 2566
2019
Q3
$696K Sell
7,225
-44,259
-86% -$4.26M ﹤0.01% 3224
2019
Q2
$5.58M Buy
51,484
+19,160
+59% +$2.08M ﹤0.01% 2054
2019
Q1
$3.8M Buy
+32,324
New +$3.8M ﹤0.01% 2267
2018
Q4
Sell
-852
Closed -$60K 4838
2018
Q3
$60K Buy
+852
New +$60K ﹤0.01% 4292
2018
Q2
Sell
-3,899
Closed -$255K 4757
2018
Q1
$255K Buy
+3,899
New +$255K ﹤0.01% 3640
2017
Q4
Sell
-201,781
Closed -$7.16M 4648
2017
Q3
$7.16M Buy
+201,781
New +$7.16M ﹤0.01% 1962